Codexis, Inc. (LON:0I0X)
1.130
-0.080 (-6.58%)
Feb 12, 2026, 3:58 PM GMT
Codexis Revenue
Codexis had revenue of $8.60M USD in the quarter ending September 30, 2025, a decrease of -32.98%. This brings the company's revenue in the last twelve months to $52.93M, down -17.87% year-over-year. In the year 2024, Codexis had annual revenue of $59.35M, down -15.39%.
Revenue (ttm)
$52.93M
Revenue Growth
-17.87%
P/S Ratio
2.00
Revenue / Employee
$281.55K
Employees
188
Market Cap
78.78M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 59.35M | -10.80M | -15.39% |
| Dec 31, 2023 | 70.14M | -68.45M | -49.39% |
| Dec 31, 2022 | 138.59M | 33.84M | 32.30% |
| Dec 31, 2021 | 104.75M | 35.70M | 51.69% |
| Dec 31, 2020 | 69.06M | 598.00K | 0.87% |
| Dec 31, 2019 | 68.46M | 7.86M | 12.98% |
| Dec 31, 2018 | 60.59M | 10.57M | 21.13% |
| Dec 31, 2017 | 50.02M | 1.19M | 2.43% |
| Dec 31, 2016 | 48.84M | 7.03M | 16.82% |
| Dec 31, 2015 | 41.80M | 6.50M | 18.40% |
| Dec 31, 2014 | 35.31M | 3.39M | 10.60% |
| Dec 31, 2013 | 31.92M | -56.38M | -63.85% |
| Dec 31, 2012 | 88.30M | -35.57M | -28.71% |
| Dec 31, 2011 | 123.87M | 16.76M | 15.65% |
| Dec 31, 2010 | 107.10M | 24.20M | 29.18% |
| Dec 31, 2009 | 82.91M | 32.43M | 64.25% |
| Dec 31, 2008 | 50.48M | 25.15M | 99.26% |
| Dec 31, 2007 | 25.33M | 13.21M | 108.90% |
| Dec 31, 2006 | 12.13M | 343.00K | 2.91% |
| Dec 31, 2005 | 11.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| hVIVO | 54.47M |
| Bioventix | 13.12M |
| Arecor Therapeutics | 5.06M |
| Scancell Holdings | 4.71M |
| SkinBioTherapeutics | 4.64M |
| 4basebio | 1.78M |
| Ondine Biomedical | 1.18M |
| ImmuPharma | -69.96K |
Codexis News
- 2 days ago - Codexis Achieves ISO 9001:2015 Certification - GlobeNewsWire
- 21 days ago - Aberdeen Group plc Expands Stake in Codexis Inc with Significant Share Acquisition - GuruFocus
- 5 weeks ago - Codexis (CDXS) Partners with Axolabs for Innovative RNA Manufacturing - GuruFocus
- 5 weeks ago - Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics - PRNewsWire
- 2 months ago - Opaleye Management Inc. Reduces Stake in Codexis Inc. - GuruFocus
- 3 months ago - Codexis (CDXS) Expands with New GMP Manufacturing Facility - GuruFocus
- 3 months ago - Codexis Announces Signing of Lease for GMP Manufacturing Facility - GlobeNewsWire
- 3 months ago - Codexis, Inc. (CDXS) Q3 2025 Earnings Call Transcript - Seeking Alpha